MedTrace Logo

F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

NCT00963755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-07-26

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that realization of guided biopsies by multimodal imaging with 18F-fluorocholine PET / CT and MR Imaging/spectroscopy would allow to increase the rate of detection prostate cancer compared with the current approach and give an information about location and tumoral volume before surgery.:

Conditions

Sponsors & Collaborators

  • Advanced Accelerator Applications

    collaborator INDUSTRY

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • John O Prior, PhD MD · University of Lausanne Hospitals

Eligibility

Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963755 on ClinicalTrials.gov